D-Rd in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes D-Rd in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes April 2025 Clinical trials Read more
2022 September Clinical practice Fixed-duration venetoclax-rituximab outperforms bendamustine-rituximab in patients with R/R CL... Read more
2022 September Clinical trials A+AVD superior to ABVD for the first-line treatment of newly diagnosed stage III or IV Hodgkin... Read more
2022 September Clinical practice New dynamic prognostic index outperforms classical IPI for the prognosis of diffuse large B-ce... Read more
2022 September Covid-19 Prophylaxis with low-molecular-weight heparin has no benefit for at-risk outpatients with COVI... Read more
2022 September Covid-19 Antibody response after vaccination against SARS-CoV-2 in patients with haematological maligna... Read more
2022 August Editor's pick relevant literature for your daily practice selected by: Kirsten Saevels Read more
Top
